Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian A Suarez

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessmentCasey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Gynecologic Oncology|February 19, 2025
Defining "enlarged" sentinel lymph nodes in the setting of endometrial cancer: What is the size cut-off?Paulina Haight, Caroline Bilbe, Courtney Riedinger, et al.
Cancer|March 2, 2024
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Cancer|September 26, 2023
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|May 13, 2023
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubblesMeghan M Newcomer, Kalpana Deepa Priya Dorayappan, Vincent Wagner, et al.
Cancer Research|January 18, 2018
<i>STAT3/PIAS3</i> Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian TubeUksha Saini, Adrian A Suarez, Shan Naidu, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Gynecologic Oncology|October 20, 2023
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution studyAshley S Felix, Jennifer A Sinnott, David E Cohn, et al.
Gynecologic Oncology|April 10, 2023
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomesMonica D Levine, David A Barrington, Caitlin E Meade, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessmentCasey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Gynecologic Oncology|February 19, 2025
Defining "enlarged" sentinel lymph nodes in the setting of endometrial cancer: What is the size cut-off?Paulina Haight, Caroline Bilbe, Courtney Riedinger, et al.
Cancer|March 2, 2024
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Cancer|September 26, 2023
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|May 13, 2023
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubblesMeghan M Newcomer, Kalpana Deepa Priya Dorayappan, Vincent Wagner, et al.
Cancer Research|January 18, 2018
<i>STAT3/PIAS3</i> Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian TubeUksha Saini, Adrian A Suarez, Shan Naidu, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Gynecologic Oncology|October 20, 2023
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution studyAshley S Felix, Jennifer A Sinnott, David E Cohn, et al.
Gynecologic Oncology|April 10, 2023
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomesMonica D Levine, David A Barrington, Caitlin E Meade, et al.
Pageof 5